MEI Pharma
Patents, Design & Utilities
Last updated:
List of all MEI Pharma patents 26 in total
| Status | Patent |
|---|---|
Application | Utility: COMBINATION THERAPY Filling date: 7 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: COMBINATION THERAPY Filling date: 7 Sep 2025 Issue date: 23 Jun 2022 |
Grant | Utility: Combination therapy Filling date: 7 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Combination therapy Filling date: 7 Sep 2025 Issue date: 19 Apr 2022 |
Application | Utility: COMBINATION THERAPIES FOR HIGH AND VERY HIGH RISK MDS Filling date: 7 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER Filling date: 7 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: TREATMENT OF B CELL MALIGNANCIES Filling date: 7 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: COMBINATION THERAPIES Filling date: 7 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: TREATMENT OF RELAPSED FOLLICULAR LYMPHOMA Filling date: 7 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: COMBINATION THERAPY Filling date: 7 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Combination therapies Filling date: 7 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Isoflavonoid compositions and methods for the treatment of cancer Filling date: 7 Sep 2025 Issue date: 13 Apr 2021 |
Application | Utility: COMBINATION THERAPIES Filling date: 7 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER Filling date: 7 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: COMBINATION THERAPY Filling date: 7 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRY- LAMIDE AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: (ALPHA-SUBSTITUTED ARALKYLAMINO AND HETEROARYLALKYLAMINO) PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN TREATING PROLIFERATIVE DISEASES Filling date: 7 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Benzimidazole derivatives: preparation and pharmaceutical applications Filling date: 7 Sep 2025 Issue date: 11 Aug 2020 |
Application | Utility: COMBINATION THERAPY Filling date: 7 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: COMBINATION THERAPY Filling date: 7 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER Filling date: 7 Sep 2025 Issue date: 23 Apr 2020 |
Grant | Utility: Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acr- ylamide and uses thereof Filling date: 7 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Filling date: 7 Sep 2025 Issue date: 31 Mar 2020 |
Application | Utility: (ALPHA-SUBSTITUTED ARALKYLAMINO AND HETEROARYLALKYLAMINO) PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN TREATING PROLIFERATIVE DISEASES Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: BENZIMIDAZOLE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS Filling date: 7 Sep 2025 Issue date: 19 Sep 2019 |
Grant | Utility: Isoflavonoid compositions and methods for the treatment of cancer Filling date: 7 Sep 2025 Issue date: 6 Aug 2019 |
Showing 1 to 26 of 26 patents.